SCR 18: REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.
- Session Year: 2025-2026
- House: Senate
- Latest Version Date: 2026-02-05
Current Status:
In Progress
(2026-03-30: The committee on HHS deferred the measure.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Final Decking
Enacted
Version:
REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.
Discussed in Hearing
29SECMar 30, 2026
Senate Standing Committee on Agriculture and Environment
29SECMar 30, 2026
Senate Standing Committee on Health and Human Services
29SECMar 30, 2026
Senate Standing Committee on Housing
29SECMar 30, 2026